Neuroimage, 2009 · DOI: 10.1016/j.neuroimage.2008.12.071 · Published: May 1, 2009
This study uses a mouse model to investigate demyelination and remyelination in the spinal cord, similar to what happens in multiple sclerosis. Lysolecithin is injected to cause demyelination, and then the body naturally tries to repair the damage. The researchers used two types of MRI (qT2 and MTR) to measure changes in the myelin (the protective coating around nerve fibers) over time. These MRI techniques provide quantitative measures of myelin content. The MRI results were compared with traditional staining methods (histology) to confirm the presence of demyelination and remyelination. The aim was to see if the MRI methods could accurately track these changes in the spinal cord.
The study suggests that multicomponent T2 MRI, specifically myelin water fraction (MWF), may be a more sensitive and accurate tool for monitoring myelin changes in MS patients compared to traditional MTR.
The research provides insights into the complex process of remyelination and highlights the differences in sensitivity between different MRI markers. This could lead to a better understanding of the mechanisms underlying remyelination and how to promote it.
The study provides a non-invasive method for evaluating the effectiveness of potential remyelinating therapies in preclinical studies. By using qT2 and MTR, researchers can track myelin changes in vivo and assess the impact of different treatments.